Isotechnika Pharma Inc IPHAF

dont forget backflips...

[antoninus]

do you remember that? god that was funny...imagine..a professional group, talking about cartwheels and backflips...not sure how someone here thinks uveitis takes us to 3 bucks! lol....what a joke! 

meanwhile, where are psoriasis and transplant? where is the transplant partner who so many said would appear next day when roche bailed? I'm still waiting....lolololololol

not sure why transplant has not been pursued more vigorously...it seems like there is a disconnect between what shareholders hope and what management has in its plans...are we not being told something? Is there not a need for voclo in the tx field so much so that not one of roche's competitors sees in us an opportunity to gain market share versus roche? 

[WASKERWISK]

With 145 million shares and multiple of only 15 you only need $30M in annual earnings to get you to $3 and that’s without built in speculation for other indications.For a whole bunch of reasons uvietis approval would be a very big deal.

[Investandpray]

   Waskerwisk, very good points. We don't know what the projected sales will be but it will not take much to get some long awaited revenues coming in maybe end of this year if all goes well. You can also add in a little psoriasis sales if approved later this year. We should easily see 30M between the 2 of these approvals by next year. 18 cents is a great bargain still. I think